NCT06239675

Brief Summary

This study aims to test if transcranial direct current stimulation (tDCS) can be applied to boost the efficacy of constraint-induced movement therapy (CIMT) in children with HCP and examine brain mechanisms related to individual outcomes.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
20mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

January 17, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
1.9 years until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

2 years

First QC Date

January 17, 2024

Last Update Submit

July 7, 2025

Conditions

Keywords

children

Outcome Measures

Primary Outcomes (2)

  • gross manual dexterity

    It will be measured by the box and block test to assess how many blocks one can move from one box to another in one minute.

    With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

  • fine manual dexterity

    It will be measured by the nine-hole peg test to assess the time one needs to place nine pins into a reservior.

    With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

Secondary Outcomes (2)

  • quality of upper extremity skill

    With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

  • finger touch sensitivity

    With the first day of the intervention defined as day 1, this measure will be assessed in one of the three days before day 1, on day 15 or day 16 or day 17, and on day 181 or day 182 or day 183.

Study Arms (2)

tDCS+CIMT

EXPERIMENTAL

Participants will receive concurrent anodal tDCS (20 minutes, 1mA\~2mA) and CIMT (2 hours) five days a week for three weeks in a row.

Device: tDCSBehavioral: CIMT

sham+CIMT

SHAM COMPARATOR

Participants will receive concurrent sham tDCS and CIMT (2 hours) five days a week for three weeks in a row.

Behavioral: CIMTDevice: sham tDCS

Interventions

tDCSDEVICE

tDCS will be delivered anodal for 20 minutes at an intensity between 1mA and 2mA for 15 sessions.

Also known as: transcranial direct current stimulation
tDCS+CIMT
CIMTBEHAVIORAL

CIMT will be administered for two hours a day, five days a week, and three weeks in a row.

Also known as: constraint induced movement therapy
sham+CIMTtDCS+CIMT
sham tDCSDEVICE

sham tDCS

sham+CIMT

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • formal diagnosis of hemiplegic cerebral palsy
  • unilateral upper limb (arm and hand) motor and sensory impairments
  • capable of understanding and following experimental instructions and procedures
  • capable of performing study procedures without assistance
  • years of age, including 5-year-old and 17-year-old

You may not qualify if:

  • brain surgery, peripheral nerve surgery, genetic disorders, other neurological disorders or injuries
  • muscle toxin injection within six months before recruitment
  • received constraint-induced movement therapy (CIMT) within one year before recruitment
  • uncontrolled seizures within one year before recruitment
  • orthopedic surgery in upper limb within one year before recruitment
  • incapable of understanding and following experimental instructions and procedures
  • non-removable metallic objects or infusion pumps in the body
  • psychoactive or myorelaxant medication during study procedures
  • less than five years of age and older than 17 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Health Medical Center Dallas

Dallas, Texas, 75235, United States

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Transcranial Direct Current StimulationConstraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesExercise TherapyPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Yanlong Song, PhD

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 17, 2024

First Posted

February 2, 2024

Study Start

January 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

Participants' identifiers and linkages between study IDs and participants' identifiers will not be shared to protect participants' privacy, rights, and confidentiality. All other individual participant data will be preserved and shared. All data to be shared will be de-identified prior to receipt by any data repository. The information needed to generate a global unique identifier for a repository will be kept for each participant.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
IPD and supporting information will be shared at the end of the study.
Access Criteria
Access to the shared IPD and supporting information will not be controlled.

Locations